Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial Results on Monday, November 8, 2004
05 November 2004 - 2:30PM
PR Newswire (US)
Guilford Pharmaceuticals to Announce Third Quarter 2004 Financial
Results on Monday, November 8, 2004 BALTIMORE, Nov. 5
/PRNewswire-FirstCall/ -- Guilford Pharmaceuticals Inc.
(NASDAQ:GLFD) will announce its third quarter 2004 financial
results on Monday, November 8, 2004 and will also host a conference
call and live audio webcast beginning at 4:00 p.m. E.T. The press
release and live webcast can be accessed by going to the Investor
Relations section of Guilford's website at
http://www.guilfordpharm.com/. Following the webcast, an archived
version of the call will be available until Monday, November 22,
2004. To participate in the live conference call, U.S. residents
should dial 800-299-7928, international callers 617-614-3926. The
participant passcode is 68168189. An audio replay of the conference
call will be available for 72 hours beginning at approximately 6:00
p.m. E.T. on November 8, 2004 through 6:00 p.m. November 11, 2004.
To access the replay, U.S. residents should dial 888-286-8010,
(int'l callers 617-801-6888), passcode 45654677. Guilford
Pharmaceuticals Inc. is a pharmaceutical company engaged in the
research, development and commercialization of products that target
the hospital market. Presently, Guilford markets two commercial
products, GLIADEL(R) Wafer (polifeprosan 20 with carmustine
implant), for the treatment of brain cancer, and AGGRASTAT(R)
Injection (tirofiban hydrochloride), a glycoprotein GP IIb/IIIa
receptor antagonist used for the treatment of acute coronary
syndrome (ACS). Guilford's product pipeline includes a novel
anesthetic, AQUAVAN(R) Injection. For additional information about
GLIADEL(R) Wafer, please visit http://www.gliadel.com/; and for
AGGRASTAT(R) Injection, please see http://www.aggrastat.com/.
CONTACT: Stacey Jurchison, Guilford Pharmaceuticals Inc.,
+1-410-631-5022, DATASOURCE: Guilford Pharmaceuticals Inc. CONTACT:
Stacey Jurchison, Guilford Pharmaceuticals Inc., +1-410-631-5022,
Web site: http://www.gliadel.com/ Web site:
http://www.aggrastat.com/ Web site: http://www.guilfordpharm.com/
Company News On-Call: http://www.prnewswire.com/comp/112882.html
Copyright
Guilford (NASDAQ:GLFD)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Guilford (NASDAQ:GLFD)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
Echtzeit-Nachrichten über Guilford Pharmaceuticals (MM) (NASDAQ): 0 Nachrichtenartikel
Weitere Guilford Pharmaceuticals (MM) News-Artikel